MOSCOW (Sputnik) – Algeria’s Ministry for Pharmaceuticals Industry on Sunday registered the Russia-developed coronavirus vaccine Sputnik V.
A press launch circulated by the ministry stated the Ministry’s National Agency for Pharmaceuticals granted authorization for administering Sputnik V beneath an government decree for pressing measures to get a vaccine marketing campaign underway within the nation.
This makes Algeria the primary nation on the African continent to register the vaccine.
So far, extra than 1.5 million folks have already acquired the Sputnik V coronavirus vaccine, the Russian Direct Investment Fund stated Sunday.
Sputnik V, developed by the Gamaleya Research Institute of Epidemiology and Microbiology, was registered by the Russian Health Ministry on August 11, changing into the primary registered vaccine in opposition to COVID-19 on the earth.